Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1211P encodes a non-functional copy (pseudogene) of the U6 small nuclear RNA gene, which originally participates in RNA splicing in the spliceosome as part of the U6 snRNA. Pseudogenes such as this are prevalent in vertebrate genomes and arise mainly by retrotransposition (often via the LINE/L1 element machinery). Unlike the functional U6 snRNA, RNU6-1211P does not encode an active RNA and is not involved in biological processes or disease. Its existence reflects genomic evolution and retrotranspositional activity, but it lacks therapeutic relevance[2][3][5]. If you need information about the functional U6 small nuclear RNA, it is a catalytic RNA within the spliceosome important for pre-mRNA splicing[1][3]. The pseudogene copy, however, is not relevant in therapeutic or biomarker contexts.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1211, pseudogene (RNU6-1211P).